Comparison of pegaspargase with concurrent radiation <i>vs</i>. P-GEMOX with sequential radiation in early-stage NK/T-cell lymphoma
P+CCRT is associated with comparable clinical outcomes compared to P-GEMOX + SERT in early-stage NKTCL, with comparable adverse events. Additionally, P+CCRT offers the benefit of a more streamlined treatment regimen with a shorter cycle. Given these encouraging results, further cohort studies are needed to validate these results.
Authors
- Demei Feng (ORCID: https://orcid.org/0009-0004-7038-3673)
- Guanjun Chen (ORCID: https://orcid.org/0000-0002-8629-2168)
- Bibo Fu
- Hailin Tang (ORCID: https://orcid.org/0000-0002-3206-782X)
- Shenrui Bai (ORCID: https://orcid.org/0000-0002-2804-6292)
- Hua Wang (ORCID: https://orcid.org/0000-0002-2605-5697)
- Liang Wang (ORCID: https://orcid.org/0000-0002-5247-6727)
- Cailu Song
Institutions
- Beijing Tongren Hospital (CN)
- Sun Yat-sen University (CN)
- Capital Medical University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
- Published
- 2024-12-19
- DOI
- https://doi.org/10.32604/or.2024.057065
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Basic and Applied Basic Research Foundation of Guangdong Province